ARTICLE | Financial News
Antibiotics play Qpex launches with Medicines Co. assets, BARDA deal
October 26, 2018 5:03 PM UTC
With $33 million in new series A funding, a portfolio of preclinical assets from The Medicines Co. (NASDAQ:MDCO) and a BARDA deal, Qpex Biopharma Inc. (San Diego, Calif.) hopes to begin clinical studies of multiple programs designed to combat antimicrobial resistance.
New Enterprise Associates led the tranched round. Also participating were Adams Street Partners, LYZZ Capital, Hatteras Venture Partners and Stanford University Draper Fund...